2026 WDL LTC Client Experience Survey: LTC Clients Only - 2-Min Survey: 2026 WDL Client Experience Survey now open through May 20. Not applicable to general outreach clients. Learn more

2026 WDL LTC Client Experience Survey

WDL

understanding your report

We understand that many times the information that you receive from your Healthcare Provider and medical reports can be full of medical jargon and can be very confusing. We developed this page to help you in understand the content within your Molecular Pathology report. As always, if you still have questions or concerns you should direct them to your HealthCare Provider.

 
top curve

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
1
1

Selected Alteration Details:

For any detected variants that are in My Cancer Genome, this section shows a summary of the information curated by My Cancer Genome, and a link to the variant's page in the MCG website

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
2
2

Test Details:

Methodology and disclaimers. Provided by the Medical College of Wisconsin

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
3
3

Electronically Signed By:

The first name, last name and suffix(es) for the pathologist who has signed off on the report.

Previous

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
1
1

Potential alteration(s) in the following genes are undergoing confirmation testing...:

If variant(s) in the Workbench have been sent out for Confirmation, and the results have not been returned at the time the Report has been finalized by the pathologist, the gene(s) in which the variant(s) exist will be denoted here. When these variants are returned, the results will be reported in a Confirmation Addendum Report.

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
2
2

Detected Alterations of Known or Potential Pathogenicity:

Variants that have been marked as 'Detected' and that are classified as 'Pathogenic' or 'Likely Pathogenic'.

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
3
3

Detected Alterations of Uncertain Significance

Variants that have been marked as 'Detected' and that are classified as 'Uncertain Significance'

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
4
4

Detected Alterations Known to Be Benign or Likely to Be Benign

Variants that have been marked as 'Detected' and that are classified as 'Benign' or 'Likely Benign'

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
5
5

Genes with No Detected Alterations of the Amino Acid Sequence:

Genes that either do not have any detected variants, or only have silent mutations.

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
1
1

Order Information associated with the current report:

This information is entered during Order creation.

Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
2
2

Patient Information, Specimen Information, Physician Information:

This information is entered during Order creation

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
3
3

Interpretation of Results

These are the Pathologist's comments

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
4
4

Drugs Associated with Sensitivity for Patient's Tumor Type, Based on Genomic Analysis

These drugs are expected to induce a positive response, based on the mutations detected. The drug response is associated with the patient's tumor type.

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
5
5

Drugs Associated with Resistance, Based on Genomic Analysis:

These drugs are expected to be ineffective, based on the mutations detected.

Previous Next

Understand your Report

Select one of the green circles labeling the report to get started, or simply click ‘next’.

Next
6
6

Clinical Trials

These are potentially relevant Clinical Trials, based on the mutations detected and demographic information available.

Previous Next

Understanding Your Report

1

Understand your Report

Select one of the green circles labeling the report to get started, or simply click 'next'.
Next
bottom curve